XML 165 R122.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Payments - Narrative (Details)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 02, 2024
USD ($)
Sep. 26, 2023
USD ($)
Jun. 30, 2024
shares
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2025
USD ($)
increment
plan
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award                  
Selling, general and administrative           $ 2,433.6 $ 2,403.7 $ 2,549.7  
Unrecognized compensation cost related to unvested share-based compensation           $ 292.6      
Weighted-average period to recognize the cost of unvested awards (in years)           1 year 10 months 24 days      
Granted (in shares) | shares           0      
Vesting period           3 years      
Shares issued under ESPP (in shares) | shares     2,500,000            
Research and development                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense           $ 115.7 154.1 296.7  
Selling, general and administrative                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense           187.8 198.6 371.7  
Human Immunology Biosciences                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense $ 56.4         0.0 56.4 0.0  
Human Immunology Biosciences | Research and development                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense 42.5                
Human Immunology Biosciences | Selling, general and administrative                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense $ 13.9                
Reata Pharmaceuticals, Inc                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Operating expenses   $ 393.4              
Selling, general and administrative   196.4              
Research and development expense   $ 197.0              
Stock Options                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share based payment arrangement, term                 10 years
Market Stock Units (MSUs)                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense           $ 0.0 0.6 4.9  
Vesting period                 3 years
Number of equal annual increments | increment           3      
Percentage of earnings of the target number of units granted based on actual stock performance           0.00%      
Percentage of earnings of the target number of units granted based on actual stock performance           200.00%      
Total fair value of vested awards             6.3 20.7  
Performance Units (PUs)                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Total fair value of vested awards             13.2 28.6  
PSUs Settled in Stock                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense           $ 42.3 48.4 35.5  
Vesting period       3 years          
Percentage of earnings of the target number of units granted based on actual stock performance           0.00%      
Percentage of earnings of the target number of units granted based on actual stock performance           200.00%      
Granted (in dollars per share) | $ / shares           $ 161.28      
PSUs Settled in Cash                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense           $ 0.0 $ (2.5) 6.8  
Vesting period         3 years   3 years    
Number of days for calculation of average closing stock price           30 days      
Total fair value of vested awards             $ 9.5 $ 11.7  
Granted (in dollars per share) | $ / shares           $ 196.13 $ 280.60 $ 383.61  
Time-Vested Restricted Stock Units (RSUs)                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share-based compensation expense           $ 249.3 $ 236.4 $ 220.0  
Vesting period           3 years      
Total fair value of vested awards           $ 141.6 $ 193.6 $ 232.1  
Granted (in dollars per share) | $ / shares           $ 141.71 $ 235.82 $ 282.92  
2017 Omnibus Equity Plan | Chief Executive Officer                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Granted (in shares) | shares                 81,000
Stock options granted, weighted average price (in dollars per share) | $ / shares                 $ 139.10
Stock options granted, grant date fair value                 $ 11.2
Vesting period                 3 years
Omnibus Equity Plan 2024                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Ratio of total number of shares reserved under the plan     1.5            
Omnibus Plan number of shares authorized (in shares) | shares     3,700,000            
2024 Omnibus Equity Plan And 2024 ESPP                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Number of share-based compensation plans pursuant to which awards are currently being made | plan           2      
Number Of Share Based Compensation Plans                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Number of share-based compensation plans pursuant to which awards are currently being made | plan           3